VTRS
Viatris Inc.
9.36
USD
This page is just a preview of the data found in TrendSpider’s full version
Viatris Inc. stock is up 0.92% since 30 days ago. The next earnings date is Feb 26, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 100% of the previous 3 December’s closed higher than November. In the last 10 Unusual Options Trades, there were 8 CALLs, 2 PUTs. 0% of analysts rate it a buy.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 23 Oct 14:24 | 16 Jan, 2026 | 5.00 | 9 | ||
| 23 Oct 18:47 | 17 Jan, 2025 | 12.00 | 3547 | ||
| 02 Nov 14:59 | 21 Jun, 2024 | 10.00 | 3047 | ||
| 02 Nov 14:59 | 21 Jun, 2024 | 10.00 | 3047 | ||
| 07 Nov 20:10 | 17 Jan, 2025 | 7.00 | 1474 | ||
| 16 Nov 15:03 | 19 Apr, 2024 | 10.00 | 550 | ||
| 17 Nov 14:33 | 17 Nov, 2023 | 6.00 | 81 | ||
| 29 Nov 19:37 | 19 Jan, 2024 | 15.00 | 80 | ||
| 01 Dec 18:04 | 21 Jun, 2024 | 10.00 | 4517 | ||
| 01 Dec 18:05 | 21 Jun, 2024 | 10.00 | 4517 |
Viatris Inc. operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology. It distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies.
